ClinicalTrials.Veeva

Menu

Timing and Intrauterine Insemination in Unexplained Infertility

S

Sohag University

Status and phase

Unknown
Phase 4

Conditions

Intrauterine Insemination

Treatments

Drug: hCG

Study type

Interventional

Funder types

Other

Identifiers

NCT03920514
Intrauterine insemination

Details and patient eligibility

About

to determine the most suitable time for administration of (human chorionic gonadotropin )hCG prior to intrauterine insemination (IUI) to optimize pregnancy outcome and to have the best success rates so the cases divided in to four groups according to the time of hCG administration .

Full description

IUI with or without ovarian stimulation is a common treatment for infertility ,it is a simple procedure the semen is prepared in the laboratory and transferred by a catheter and injected intrauterine .ultrasound folliculometry is used for monitoring follicular growth where some clinicians prefer the natural cycles and others prefer ovarian stimulation and human chorionic gonadotropin (hCG)trigger for better timing .so cases will take induction and folliculometry will be done until the follicle reach 18mm trigger with hCG .women will be randomly divided to four groups .the first group will undergo IUI at 24 after trigger the second IUI at36 hour after trigger the thirdG at 48 after trigger and finaly the last group IUI will be done simultaneos with trigger the out come the number of pregnant women for each group.

Enrollment

80 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mild male infertility or unexplained infertility

Exclusion criteria

  • Adanced male factor endometriosis uterine abnormality sever semen parameters i impairment according to WHO 2010 non ovulatory cycles bilatral tubal block

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 4 patient groups

GROUP 1
Active Comparator group
Description:
IUI 24 hours after hCGadminstration
Treatment:
Drug: hCG
GROUP 2
Active Comparator group
Description:
IUI 36 hours after hCG adminstration
Treatment:
Drug: hCG
GROUP 3
Active Comparator group
Description:
IUI 48 hours after hCG adminstration
Treatment:
Drug: hCG
GROUP 4
Active Comparator group
Description:
IUI at time of hCG adminstration
Treatment:
Drug: hCG

Trial contacts and locations

0

Loading...

Central trial contact

Mohamed Sabry Ebrahim, Lecture of obs and gyn; Salwa Sabry Ahmed, Candidate

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems